RENASANT CORP Earnings Per Share Disclosure
| Year Ended December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Basic | |||||||||||||||||
| Net income applicable to common stock | $ | 195,457 | $ | 144,678 | $ | 166,068 | |||||||||||
| Average common shares outstanding | 59,350,157 | 56,099,689 | 55,904,579 | ||||||||||||||
| Net income per common share—basic | $ | 3.29 | $ | 2.58 | $ | 2.97 | |||||||||||
| Diluted | |||||||||||||||||
| Net income applicable to common stock | $ | 195,457 | $ | 144,678 | $ | 166,068 | |||||||||||
| Average common shares outstanding | 59,350,157 | 56,099,689 | 55,904,579 | ||||||||||||||
| Effect of dilutive stock-based compensation | 398,633 | 348,474 | 309,651 | ||||||||||||||
| Average common shares outstanding—diluted | 59,748,790 | 56,448,163 | 56,214,230 | ||||||||||||||
| Net income per common share—diluted | $ | 3.27 | $ | 2.56 | $ | 2.95 | |||||||||||
| Year Ended | |||||||||||||||||
| December 31, | |||||||||||||||||
| 2024 | 2023 | 2022 | |||||||||||||||
| Number of shares | — | 6,600 | 9,250 | ||||||||||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.